Stock Events

Stock Events

Seer 

$1.7
10
+$0+0% Thursday 20:00

Statistics

Day High
1.71
Day Low
1.67
52W High
2.41
52W Low
1.62
Volume
61,806
Avg. Volume
269,914
Mkt Cap
95.92M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.39
-0.35
-0.32
-0.28
Expected EPS
-0.28
Actual EPS
N/A

Financials

-443.96%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
33.16MRevenue
-147.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SEER. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, directly competing with Seer's proteomics and analytical tools.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing and array-based technologies, competing in the broader life sciences market alongside Seer's proteomics focus.
Waters
WAT
Mkt Cap20.81B
Waters Corporation specializes in liquid chromatography and mass spectrometry, technologies that are foundational to proteomics research, making it a direct competitor.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies offers a broad portfolio of instruments, software, services, and consumables for laboratory workflow, directly competing with Seer in the life sciences sector.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a range of products for the life science research and clinical diagnostics markets, overlapping with Seer's target market.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, including for proteomics, directly competing with Seer's technology offerings.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers genomic analysis systems, competing in the broader genomics and life sciences space where Seer operates.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the life sciences market by offering complementary technologies to Seer's.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the life sciences tools market.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation owns a portfolio of life sciences companies, offering products and services that compete across several of Seer's key areas.

About

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Show more...
CEO
Dr. Omid C. Farokhzad M.D., Ph.D.
Employees
134
Country
US
ISIN
US81578P1066

Listings

BOATS
BOATS
SEER.BOATS
XNAS
US
SEER

0 Comments

Share your thoughts

FAQ

What is Seer stock price today?▼
The current price of SEER is $1.7 USD — it has increased by +0% in the past 24 hours. Watch Seer stock price performance more closely on the chart.
What is Seer stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Seer stocks are traded under the ticker SEER.
Is Seer stock price growing?▼
SEER stock has risen by +2.41% compared to the previous week, the month change is a -5.56% fall, over the last year Seer has showed a +2.41% increase.
What is Seer market cap?▼
Today Seer has the market capitalization of 95.92M
When is the next Seer earnings date?▼
Seer is going to release the next earnings report on May 12, 2026.
What were Seer earnings last quarter?▼
SEER earnings for the last quarter are -0.29 USD per share, whereas the estimation was -0.32 USD resulting in a +9.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Seer revenue for the last year?▼
Seer revenue for the last year amounts to 33.16M USD.
What is Seer net income for the last year?▼
SEER net income for the last year is -147.2M USD.
How many employees does Seer have?▼
As of April 03, 2026, the company has 134 employees.
In which sector is Seer located?▼
Seer operates in the Health Care sector.
When did Seer complete a stock split?▼
Seer has not had any recent stock splits.
Where is Seer headquartered?▼
Seer is headquartered in Redwood City, US.